Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced a strategic partnership with a specialist health technology investor. [ + ]

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health emergency of international concern, an update on risk to Australia has been released. [ + ]

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT Government and the Aboriginal Community Controlled Health Sector. [ + ]

Providing guidance, tools and resources to help Australian businesses use AI safely, the Australian Government has launched the National AI Centre. [ + ]

The life sciences industry body has responded to measures set out in the Australian Government's Budget 2026–27, welcoming some measures while expressing caution about others. [ + ]

In Queensland, all inherited sexual assault examination kits have been processed and a backlog of major crime DNA samples reduced by 70%, the government has announced. [ + ]

The Australian CDC has provided an update on hantavirus risk to Australians and infection protection and control measures for returning MV Hondius passengers. [ + ]

Investments under the Global Science and Technology Diplomacy Fund will support nine international projects, with six to involve Japan as a key partner. [ + ]

The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University Innovation Precinct will produce new and existing RNA therapeutics. [ + ]

To support immune cell therapy products for the treatment of cancer and endometriosis, Australian biotech Cartherics has announced an enhanced partnership with Catalent. [ + ]

Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is intended to grow a regionally embedded but globally responsive partnership. [ + ]

The Lipid Network launched this month to build links between researchers, clinicians and industry across the diverse and rapidly evolving field of lipid science. [ + ]

Australian clinical-stage biotech company Noxopharm Limited has appointed Dr Olivier Laczka as its Chief Executive Officer. [ + ]

Utilising networks of GPs across three states, a large-scale study intends on combining digital cognitive tests and blood tests for people at risk of Alzheimer's. [ + ]

To build on the National AI Plan launched last year, the Australian Government has signed a new collaborative Memorandum of Understanding with Anthropic. [ + ]